Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03112902 · ClinicalTrials.gov registry record · NA
Application of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive Performance
A NA study, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03112902 is a NA study that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 24 participants.
The verdict
NCT03112902, a NA study, was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Loss of slow wave sleep (SWS) is common in mild cognitive impairment (MCI) and Alzheimer's disease, and is thought to worsen thinking, memory and brain degeneration. Initial studies suggest that correction of sleep deterioration may slow the progression of brain damage in mild cognitive impairment, and might be able to stop the development of Alzheimer's disease. Transcranial alternating current stimulation (tACS) uses electrodes to deliver very small amounts of electricity through the brain, with direct effects on brain cell function. Transcranial electric stimulation has been demonstrated to enhance slow wave sleep and to improve memory when applied during sleep in healthy adults. The purpose of this research is to investigate tACS to modulate sleep, thinking/memory, mood, and quality of life among normal healthy adults, older adults, as well as individuals with MCI.
Interventions
- DEVICE Application of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive Performance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-03-07 |
| Est. Completion | 2021-05-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03112902
The ClinicalTrials.gov registry entry for NCT03112902 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Application of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive Performance is the first listed.
NCT03112902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03112902 about?
NCT03112902 is a clinical study titled "Application of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive Performance". Loss of slow wave sleep (SWS) is common in mild cognitive impairment (MCI) and Alzheimer's disease, and is thought to worsen thinking, memory and brain degeneration. Initial studies suggest that correction of sleep deterioration may slow the progression of brain damage in mild cognitive impairment, ...
What is the current status of trial NCT03112902?
This trial is currently terminated. It is a NA study. The enrollment target is 24 participants. The study started on 2018-03-07. Estimated completion is 2021-05-04.
What interventions are being tested in trial NCT03112902?
The interventions under investigation include: Application of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive Performance (DEVICE).
Who is sponsoring clinical trial NCT03112902?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.